RNA Stucturomics

A new high-throughput, transcriptome-wide assay determines RNA structures in vivo.

Written byRuth Williams
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

SHAPE CATCHER: To determine the secondary structures of RNAs in their natural cellular context (1), an unpaired nucleotide (orange) is first modified with NAI-N3 (2). Next, biotin clicks onto the NAI-N3 (3) allowing retrieval of the modified RNA via biotin binding to a streptavidin bead. The RNA is then chopped into small fragments (4) for sequencing to reveal which nucleotide is modified and thus unpaired (orange) versus unmodified and thus paired or bound to a protein (green). If these in vivo modifications, analyzed across the transcriptome and among many copies of each RNA, are compared with those seen on the same RNAs in vitro (5), potential protein binding sites (1) and other structural differences can be revealed because the probe will bind to different bases.© GEORGE RETSECK

Like pieces of sticky tape, single-stranded RNA molecules can fold over and bind to themselves, via base pairing. Determining the complicated three-dimensional structures such folding creates can reveal the RNAs’ functions, but classic techniques for investigating molecular structure, such as X-ray crystallography, are “very laborious” in that they “can only be used on one RNA at a time,” says Howard Chang of Stanford University.

To study the secondary structures of multiple RNAs simultaneously, researchers have come up with chemical modification techniques that detect unpaired nucleotides in a pool of RNA molecules. Subsequent sequencing of the RNAs reveals the patterns of modified and unmodified bases (their unpaired or paired statuses) and thus indicates how each RNA molecule folds. One of these transcriptome-wide techniques, however, only targets ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • ruth williams

    Ruth is a freelance journalist. Before freelancing, Ruth was a news editor for the Journal of Cell Biology in New York and an assistant editor for Nature Reviews Neuroscience in London. Prior to that, she was a bona fide pipette-wielding, test tube–shaking, lab coat–shirking research scientist. She has a PhD in genetics from King’s College London, and was a postdoc in stem cell biology at Imperial College London. Today she lives and writes in Connecticut.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies